Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PALB2, ENSG00000083093, 79728 AND Diagnosis
9 results:

  • 1. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and palb2 in endometrial cancer.
    Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
    Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predicted Chemotherapy Benefit for Breast cancer Patients With Germline Pathogenic Variants in cancer Susceptibility Genes.
    Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Katz SJ
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426465
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Report of a germline double heterozygote in MSH2 and palb2.
    Agiannitopoulos K; Papadopoulou E; Tsaousis GN; Pepe G; Kampouri S; Patsea E; Lypas G; Nasioulas G
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1242. PubMed ID: 32853479
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cancer Susceptibility Gene Mutations in Individuals With colorectal cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
    Susswein LR; Marshall ML; Nusbaum R; Vogel Postula KJ; Weissman SM; Yackowski L; Vaccari EM; Bissonnette J; Booker JK; Cremona ML; Gibellini F; Murphy PD; Pineda-Alvarez DE; Pollevick GD; Xu Z; Richard G; Bale S; Klein RT; Hruska KS; Chung WK
    Genet Med; 2016 Aug; 18(8):823-32. PubMed ID: 26681312
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hereditary ovarian cancer: not only BRCA 1 and 2 genes.
    Toss A; Tomasello C; Razzaboni E; Contu G; Grandi G; Cagnacci A; Schilder RJ; Cortesi L
    Biomed Res Int; 2015; 2015():341723. PubMed ID: 26075229
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
    Grant RC; Selander I; Connor AA; Selvarajah S; Borgida A; Briollais L; Petersen GM; Lerner-Ellis J; Holter S; Gallinger S
    Gastroenterology; 2015 Mar; 148(3):556-64. PubMed ID: 25479140
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genetic susceptibility to pancreatic cancer.
    Klein AP
    Mol Carcinog; 2012 Jan; 51(1):14-24. PubMed ID: 22162228
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.